These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37284387)

  • 21. A Comparative Analysis of a Self-Reported Adverse Events Analysis after Receiving One of the Available SARS-CoV-2 Vaccine Schemes in Ecuador.
    Ortiz-Prado E; Izquierdo-Condoy JS; Fernandez-Naranjo R; Simbaña-Rivera K; Vásconez-González J; Naranjo EPL; Cordovez S; Coronel B; Delgado-Moreira K; Jimbo-Sotomayor R
    Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perceptions and experiences of COVID-19 vaccines' side effects among healthcare workers at an Egyptian University Hospital: a cross-sectional study.
    Orebi HA; Emara HE; Alhindi AA; Shahin MR; Hegazy AH; Kabbash IA; Saied SM
    Trop Med Health; 2022 May; 50(1):37. PubMed ID: 35637513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse events following immunisation of COVID-19 vaccine among health care workers in the first phase of vaccination.
    Rahmat H; Leelavathi M; Wan Ismail WF
    Med J Malaysia; 2022 Nov; 77(6):637-642. PubMed ID: 36448378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
    Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
    Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Needle size for vaccination procedures in children and adolescents.
    Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F
    Cochrane Database Syst Rev; 2015 Jun; (6):CD010720. PubMed ID: 26086647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Actual Status of Hospitals as COVID-19 Vaccination Clinics in China and Safety Monitoring of Inactivated Vaccine: A Cross-Sectional Study.
    Huang J; Zhang MQ; Huang MZ; Lin GM
    Disaster Med Public Health Prep; 2022 Aug; 17():e256. PubMed ID: 36017705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Adverse Events Related to Inactivated COVID-19 Vaccines and Novavax;a Systematic Review.
    Dadras O; Mehraeen E; Karimi A; Tantuoyir MM; Afzalian A; Nazarian N; Mojdeganlou H; Mirzapour P; Shamsabadi A; Dashti M; Ghasemzadeh A; Vahedi F; Shobeiri P; Pashaei Z; SeyedAlinaghi S
    Arch Acad Emerg Med; 2022; 10(1):e54. PubMed ID: 36033990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous adverse events following 771 doses of the inactivated and mRNA COVID-19 vaccines: A survey study among health care providers.
    Bostan E; Yel B; Karaduman A
    J Cosmet Dermatol; 2022 Sep; 21(9):3682-3688. PubMed ID: 35775860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of COVID-19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical-year medical students in Indonesia.
    Heriyanto RS; Kurniawan A; Wijovi F; Halim DA; Jodhinata C; Marcella E; Susanto B; Wibowo J; Indrawan M; Heryadi NK; Imanuelly M; Anurantha JJ; Hariyanto TI; Marcellin C; Sinaga TD; Rizki SA; Sieto N; Siregar JI; Lugito NPH
    Int J Infect Dis; 2021 Dec; 113():336-338. PubMed ID: 34653654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 Vaccine-Related Arthritis: A Descriptive Study of Case Reports on a Rare Complication.
    Dawoud R; Haddad D; Shah V; Patel V; Abbas G; Guduru S; Dakka A; Kaushik V; Cheriyath P
    Cureus; 2022 Jul; 14(7):e26702. PubMed ID: 35959192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tracking Side Effects of the COVID-19 Vaccine in Mymensingh District of Bangladesh.
    Khan MK; Ferdous J; Akhter S; Esha AM; Islam M
    Mymensingh Med J; 2022 Jan; 31(1):1-9. PubMed ID: 34999672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Side effects of COVID-19 vaccines and perceptions about COVID-19 and its vaccines in Bangladesh: A Cross-sectional study.
    Mohsin M; Mahmud S; Uddin Mian A; Hasan P; Muyeed A; Taif Ali M; Faysal Ahmed F; Islam A; Maliha Rahman M; Islam M; Rahaman Khan MH; Shafiqur Rahman M
    Vaccine X; 2022 Dec; 12():100207. PubMed ID: 36032698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study.
    El-Shitany NA; Harakeh S; Badr-Eldin SM; Bagher AM; Eid B; Almukadi H; Alghamdi BS; Alahmadi AA; Hassan NA; Sindi N; Alghamdi SA; Almohaimeed HM; Mohammedsaleh ZM; Al-Shaikh TM; Almuhayawi MS; Ali SS; El-Hamamsy M
    Int J Gen Med; 2021; 14():1389-1401. PubMed ID: 33907443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 vaccination side effects among the child age group: a large cross-sectional online based survey in Saudi Arabia.
    Alwafi H; Naser AY; Aldhahir AM; Alhazmi A; Alosaimi AN; Mandili RA; Majeed Z; Salawati E; Ekram R; Samannodi M; Assaggaf H; Almatrafi M; Alqahtani JS; Alsanosi SM; Minshawi F
    BMC Infect Dis; 2022 Dec; 22(1):911. PubMed ID: 36474174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance of Side Effects after Two Doses of COVID-19 Vaccines among Patients with Comorbid Conditions: A Sub-Cohort Analysis from Saudi Arabia.
    Mallhi TH; Khan YH; Butt MH; Salman M; Tanveer N; Alotaibi NH; Alzarea AI; Alanazi AS
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactogenicity of COVID-19 Vaccines in Patients With a History of COVID-19 Infection: A Survey Conducted in Pakistan.
    Riyyan M; Sarwar HA; Chania HA; Sajid S; Hotwani S; Sarwar HU; Nawaz S; Abid S
    Cureus; 2022 Nov; 14(11):e31359. PubMed ID: 36514568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Side Effects Associated With Homologous and Heterologous COVID-19 Vaccines: A Cross-Sectional Study in Saudi Arabia.
    Mohammed RA; Yazbik RS; Baajajah LH; Alharthy SF; Alsalahi H; Mahjaa MA; Barakat MM; Badawy MI; Sultan I
    Cureus; 2023 Jan; 15(1):e34030. PubMed ID: 36814743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of antibody response after two doses of the Sinovac vaccine and the potential need for booster doses in cancer patients.
    Ata S; Cil T; Duman BB; Unal N
    J Med Virol; 2022 Jun; 94(6):2487-2492. PubMed ID: 35181932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety Profile of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season.
    Salamanca de la Cueva I; Cinconze E; Eckermann T; Nwoji U; Godderis L; Lu E; Martínez-Gómez X; Wang H; Yanni E
    Drug Saf; 2021 Dec; 44(12):1375-1390. PubMed ID: 34694589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV vaccine: A comparative study among healthcare professionals of Nepal.
    Rayamajhi S; Rafi MA; Tripathi N; Dongol AS; Pandey M; Rayamajhi S; Bhandari S; Shrestha P; Hasan MT; Hossain MG
    PLoS One; 2022; 17(8):e0272729. PubMed ID: 35947626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.